» Articles » PMID: 31508368

Exogenous Let-7a-5p Induces A549 Lung Cancer Cell Death Through BCL2L1-Mediated PI3Kγ Signaling Pathway

Overview
Journal Front Oncol
Specialty Oncology
Date 2019 Sep 12
PMID 31508368
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Elevated expression of let-7a-5p contributes to suppression of lung cancer, in which let-7a-5p, as exosome cargo, can be transported from macrophages to lung cancer cells, yet the role of let-7a-5p remains unclear. Utilizing bioinformatics methods and cellular experiments, this study was designed and conducted to identify let-7a-5p regulatory network in lung cancer. Bioinformatics analysis and Kaplan-Meier survival analysis revealed that let-7a-5p could directly target BCL2L1, and aberrant expression of let-7a-5p affects the survival of lung cancer patients, which was confirmed in A549 lung cancer cells using luciferase reporter assay. Moreover, let-7a-5p inhibited BCL2L1 expression and suppressed lung cancer cell proliferation, migration, and invasion. Functionally, overexpression of let-7a-5p promoted both autophagy and cell death in A549 lung cancer cells through PI3Kγ signaling pathway, whereas the apoptosis and pyroptosis of A549 lung cancer cells were unaffected. Furthermore, aberrant expression of BCL2L1 significantly altered the expression of lung cancer biomarkers such as MYC, EGFR, and Vimentin. To sum up, these data demonstrate that exogenous let-7a-5p induces A549 lung cancer cell death through BCL2L1-mediated PI3Kγ signaling pathway, which may be a useful target for lung cancer treatment.

Citing Articles

Exosome therapeutics for non-small cell lung cancer tumorigenesis.

Orooji N, Fadaee M, Kazemi T, Yousefi B Cancer Cell Int. 2024; 24(1):360.

PMID: 39478574 PMC: 11523890. DOI: 10.1186/s12935-024-03544-6.


Integrating Network Pharmacology and Experimental Validation to Explore the Effects and Mechanisms of Qinghao Biejia Decoction and Its Active Compound Artemisinin B Against Non-Small-Cell Lung Cancer.

Ye Y, Yang Y, Yan L, Zhou L, Yu S, Du Q Drug Des Devel Ther. 2023; 17:2461-2479.

PMID: 37637262 PMC: 10460181. DOI: 10.2147/DDDT.S414098.


Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeutics.

Yuen J, Fesler A, Hwang G, Chen L, Ju J Mol Ther. 2022; 30(11):3450-3461.

PMID: 35933584 PMC: 9637772. DOI: 10.1016/j.ymthe.2022.07.015.


An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer.

Jayasingam S, Citartan M, Mat Zin A, Rozhdestvensky T, Tang T, Chng E Int J Mol Sci. 2022; 23(13).

PMID: 35805995 PMC: 9266835. DOI: 10.3390/ijms23136994.


Immune cells-derived exosomes function as a double-edged sword: role in disease progression and their therapeutic applications.

Hazrati A, Soudi S, Malekpour K, Mahmoudi M, Rahimi A, Hashemi S Biomark Res. 2022; 10(1):30.

PMID: 35550636 PMC: 9102350. DOI: 10.1186/s40364-022-00374-4.


References
1.
Zhang L, Hao C, Zhai R, Wang D, Zhang J, Bao L . Downregulation of exosomal let-7a-5p in dust exposed- workers contributes to lung cancer development. Respir Res. 2018; 19(1):235. PMC: 6267915. DOI: 10.1186/s12931-018-0949-y. View

2.
Gao L, Qi H, Kamana K, Zhang X, Zhang H, Baker P . Excessive autophagy induces the failure of trophoblast invasion and vasculature: possible relevance to the pathogenesis of preeclampsia. J Hypertens. 2014; 33(1):106-17. DOI: 10.1097/HJH.0000000000000366. View

3.
Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View

4.
Bhutia S, Mukhopadhyay S, Sinha N, Das D, Panda P, Patra S . Autophagy: cancer's friend or foe?. Adv Cancer Res. 2013; 118:61-95. PMC: 4349374. DOI: 10.1016/B978-0-12-407173-5.00003-0. View

5.
Maejima Y, Isobe M, Sadoshima J . Regulation of autophagy by Beclin 1 in the heart. J Mol Cell Cardiol. 2015; 95:19-25. PMC: 4861696. DOI: 10.1016/j.yjmcc.2015.10.032. View